Provided by Tiger Fintech (Singapore) Pte. Ltd.

PDS Biotechnology Corporation

1.56
-0.0900-5.45%
Volume:396.66K
Turnover:635.06K
Market Cap:71.31M
PE:-1.66
High:1.66
Open:1.64
Low:1.56
Close:1.65
Loading ...

PDS Biotechnology Corporation Announces Promising Phase 3 Clinical Trial Targeting HPV16-Positive Head and Neck Cancer

Reuters
·
02 Jun

PDS Biotech Unveils Updated Positive Data From Versatile-002 Trial and Additional Trials Evaluating Versamune® Hpv to Treat Head and Neck Cancers at the 2025 American Society of Clinical Oncology (Asco) Annual Meeting

THOMSON REUTERS
·
02 Jun

PDS Biotech Announces Positive Extended Follow-up Data for Versatile-002 and Additional Trials Evaluating Versamune® Hpv to Be Presented at the 2025 American Society of Clinical Oncology (Asco) Annual Meeting

THOMSON REUTERS
·
23 May

PDS Biotechnology (PDSB) Initiated with a Buy at B.Riley Financial

TIPRANKS
·
20 May

PDS Biotechnology Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

PDS Biotechnology Q1 EPS $(0.21) Beats $(0.25) Estimate

Benzinga
·
14 May

PDS Biotechnology Corp - Q1 Net Loss Approx $8.5 Mln , or $0.21 per Basic and Diluted Share

THOMSON REUTERS
·
14 May

PDS Biotech Reports First Quarter 2025 Financial Results and Provides Clinical Programs and Corporate Update

THOMSON REUTERS
·
14 May

PDS Biotechnology Corp expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
12 May

BRIEF-Pds Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
10 May

PDS Biotechnology Corp : B. Riley Cuts Target Price to $5 From $7

THOMSON REUTERS
·
21 Apr

BRIEF-Pds Biotech Announces Pds01adc Clinical Data To Be Presented At The American Association For Cancer Research

Reuters
·
08 Apr

PDS Biotech Announces PDS01ADC Clinical Data to Be Presented at the American Association for Cancer Research (Aacr) Annual Meeting 2025

THOMSON REUTERS
·
08 Apr

PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025

GlobeNewswire
·
08 Apr

PDS Biotechnology Corp (PDSB) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

GuruFocus.com
·
28 Mar

Q4 2024 PDS Biotechnology Corp Earnings Call

Thomson Reuters StreetEvents
·
28 Mar

PDS Biotechnology Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
28 Mar

PDS Biotechnology Corp : H.c. Wainwright Cuts Target Price to $13 From $21

THOMSON REUTERS
·
27 Mar

PDS Biotechnology Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Mar

PDS Biotechnology FY 2024 GAAP EPS $(1.03) Beats $(1.11) Estimate

Benzinga
·
27 Mar